Novartis AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NVSEF research report →
About the company
Novartis AG, a global pharmaceutical enterprise established in 1996 and based in Basel, Switzerland, is engaged in the entire lifecycle of healthcare products, from research and development to manufacturing and worldwide commercialization. The company's operations are divided into two main divisions: Innovative Medicines and Sandoz. The Innovative Medicines segment is dedicated to providing advanced prescription medications to both patients and healthcare professionals.
- CEO
- Vasant Narasimhan
- IPO
- 2010
- Employees
- 75,883
- HQ
- Basel, CH
Price Chart
- Market Cap
- $301.94B
- P/E
- 22.82
- P/S
- 5.48
- P/B
- 7.87
- EV/EBITDA
- 15.44
- Div Yield
- 2.89%
- Gross Margin
- 75.13%
- Op Margin
- 29.88%
- Net Margin
- 24.31%
- ROE
- 31.54%
- ROIC
- 14.89%
- Revenue
- $57.13B · 10.45%
- Net Income
- $14.65B · 22.68%
- EPS
- $7.56 · 27.70%
- Op Income
- $17.80B
- FCF YoY
- 33.53%
- 52W High
- $171.29
- 52W Low
- $110.74
- 50D MA
- $146.22
- 200D MA
- $142.00
- Beta
- 0.49
- Avg Volume
- 23.14K
Get TickerSpark's AI analysis on NVSEF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our NVSEF coverage
Recent articles, reports, and earnings notes.
No research on NVSEF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NVSEF report →Similar companies
Peers in the same neighborhood.